#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Diffuse large B-cell lymphoma recurrent Cystic fibrosis respiratory infection suppression Antisynthetase syndrome Hereditary hypophosphataemic rickets Transplant rejection NTRK gene fusion overexpression Acquired haemophilia Chronic lymphocytic leukaemia refractory Lupus nephritis Immune-mediated myositis Rheumatoid arthritis Vaginal cancer Thrombocytosis Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma – Trials in Disease Combined immunodeficiency – Treatment Mucopolysaccharidosis II – Basic Information Metachromatic leukodystrophy – Diagnostics Hepatoblastoma – Trials in Disease Noonan syndrome – Diagnostics Niemann-Pick disease – Trials in Disease Hereditary angioedema – Diagnostics Chondrosarcoma – Trials in Disease Prader-Willi syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lamotrigine Noradrenaline Tartrate Azacitidine Vsf1.01 Oxygen Selpercatinib Chlorphenamine Tramadol Hydrochloride Ozanimod Oxycodone Hydrochloride Motixafortide Lasmiditan Glucose Monohydrate Ph. Eur. GSKVX000000044501 Phentermine Albumin Dicloxacillin Troriluzole Vibozilimod Ag-946 More therapies…

    Learn about Your Condition

    Pneumonia bacterial Tetanus Osteogenesis imperfecta Chronic hepatic failure Niemann-Pick disease Staphylococcal bacteraemia Non-small cell lung cancer Pituitary tumour benign Acquired haemophilia Dementia Alzheimer's type Septic shock Angelman's syndrome Corneal graft failure Neuroblastoma Peritoneal sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effect of Caffeine Citrate for Patients with Extubation Failure and Bronchopulmonary Dysplasia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    • Infantile apnoea
    • Neonatal respiratory failure
    Investigated Drugs:
    • Caffeine Citrate
    Hungary

  • Study on the Effects of Prednisolone Acetate and Placebo Eye Drops for Patients with Chronic Central Serous Chorioretinopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Central serous chorioretinopathy
    Investigated Drugs:
    • Dextran 70
    • Hypromellose
    • Prednisolone Acetate
    The Netherlands

  • Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy

  • Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

    Recruiting

    3 1 1
    Investigated Drugs:
    • Deucrictibant
    Austria Bulgaria France Germany Hungary Ireland +5

  • Long-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Atacicept
    Belgium Czechia Germany Greece Poland Spain

  • Study on Protamine Sulfate for Reducing Bleeding and Ischemic Events in Adults with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

    Recruiting

    3 1 1
    Investigated Drugs:
    • Protamine Sulfate
    Austria Germany
Previous Page
1 … 264 265 266 267 268 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!